S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
OTCMKTS:PURE

PURE Bioscience (PURE) Stock Price, News & Analysis

$0.08
0.00 (0.00%)
(As of 04/15/2024 ET)
Today's Range
$0.08
$0.08
50-Day Range
$0.07
$0.11
52-Week Range
$0.07
$0.17
Volume
1,520 shs
Average Volume
33,694 shs
Market Capitalization
$8.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PURE stock logo

About PURE Bioscience Stock (OTCMKTS:PURE)

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.

PURE Stock Price History

PURE Stock News Headlines

PURE Bioscience, Inc. (PURE)
A.I. “Perfect Storm” Could Send THESE Stocks Sky High
A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.
A.I. “Perfect Storm” Could Send THESE Stocks Sky High
A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.
Q4 2023 Arcus Biosciences Inc Earnings Call
PURE Bioscience Inc PURE
See More Headlines
Receive PURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/18/2024
Today
4/16/2024
Next Earnings (Estimated)
6/12/2024
Fiscal Year End
7/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous chemical products
Sub-Industry
N/A
Current Symbol
OTCMKTS:PURE
Employees
11
Year Founded
1992

Profitability

Net Income
$-3,960,000.00
Net Margins
-194.80%
Pretax Margin
-124.61%

Debt

Sales & Book Value

Annual Sales
$1.87 million

Miscellaneous

Free Float
65,145,000
Market Cap
$8.95 million
Optionable
Not Optionable
Beta
0.07

Social Links

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Robert F. Bartlett (Age 79)
    President, CEO & Director
    Comp: $129.8k
  • Mr. Mark Stuart Elliott (Age 49)
    VP of Finance and Principal Financial & Accounting Officer
    Comp: $180k
  • Mr. Thomas Richard Myers (Age 71)
    Executive VP of Technology & Development and Director
    Comp: $200k

PURE Stock Analysis - Frequently Asked Questions

How have PURE shares performed in 2024?

PURE Bioscience's stock was trading at $0.1297 at the beginning of the year. Since then, PURE shares have decreased by 38.3% and is now trading at $0.08.
View the best growth stocks for 2024 here
.

Are investors shorting PURE Bioscience?

PURE Bioscience saw a decline in short interest during the month of March. As of March 15th, there was short interest totaling 400 shares, a decline of 97.7% from the February 29th total of 17,200 shares. Based on an average daily volume of 44,000 shares, the days-to-cover ratio is currently 0.0 days.
View PURE Bioscience's Short Interest
.

When is PURE Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024.
View our PURE earnings forecast
.

How were PURE Bioscience's earnings last quarter?

PURE Bioscience, Inc. (OTCMKTS:PURE) issued its earnings results on Monday, March, 18th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company earned $0.33 million during the quarter. PURE Bioscience had a negative trailing twelve-month return on equity of 717.03% and a negative net margin of 194.80%.

What other stocks do shareholders of PURE Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PURE Bioscience investors own include NVIDIA (NVDA), Boeing (BA), Overstock.com (OSTK), Pure Storage (PSTG), Riot Platforms (RIOT), Enphase Energy (ENPH), Mastercard (MA), Main Street Capital (MAIN), Twilio (TWLO) and

How do I buy shares of PURE Bioscience?

Shares of PURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PURE) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners